MCKESSON CORP
424B3, 1997-09-30
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: PLAY CO TOYS & ENTERTAINMENT CORP, SB-2/A, 1997-09-30
Next: CASCADE FINANCIAL CORP, 10-K, 1997-09-30






                             PROSPECTUS SUPPLEMENT
                      (TO PROSPECTUS DATED JUNE 18, 1997)

               4,000,000 TRUST CONVERTIBLE PREFERRED SECURITIES
                           MCKESSON FINANCING TRUST
                   5% TRUST CONVERTIBLE PREFERRED SECURITIES
          (LIQUIDATION AMOUNT $50 PER CONVERTIBLE PREFERRED SECURITY)
                 GUARANTEED TO THE EXTENT SET FORTH HEREIN BY
                             MCKESSON CORPORATION
                             --------------------

        This Prospectus Supplement supplements and amends the Prospectus
   dated June 18, 1997 (the "Prospectus") relating to the 5% Trust
   Convertible Preferred Securities (the "Convertible Preferred
   Securities"), which represent preferred undivided beneficial interests
   in the assets of McKesson Financing Trust, a statutory business trust
   formed under the laws of the State of Delaware, and the shares of common
   stock, par value $.01 per share ("McKesson Common Stock"), of McKesson
   Corporation, a Delaware corporation ("McKesson"), issuable upon
   conversion of the Convertible Preferred Securities.

        McKesson and AmeriSource Health Corporation ("AmeriSource"), a
   leading U.S. wholesale distributor of pharmaceutical and related health
   care products and services, have signed a definitive merger agreement
   providing for McKesson to acquire AmeriSource. Under the terms of the
   agreement, stockholders of AmeriSource will receive a fixed exchange
   ratio of 0.71 shares of McKesson common stock for each share of
   AmeriSource common stock. McKesson will issue approximately 17.4 million
   new shares of common stock in the merger, and will assume the long-term
   debt of AmeriSource which was approximately $532.3 million at June 30,
   1997. The merger of the two companies has been structured as a tax-free
   transaction and will be accounted for as a pooling of interests. The
   combined company will operate under the McKesson name and will be
   headquartered in San Francisco.

        Upon completion of the merger, R. David Yost, currently president
   and chief executive officer of AmeriSource, will become group president
   of the AmeriSource Services Group and a McKesson corporate vice
   president. Also upon completion of the merger, McKesson's board of
   directors will be expanded from nine to twelve members, which will
   include Yost and another two directors to be named from AmeriSource.

        Subject to regulatory approval and shareholder approval of both
   companies, the transaction is expected to be completed in early 1998.
   There can be no assurance that the merger will be completed, or that it
   will be completed as contemplated.

        The table on pages 56 through 58 of the Prospectus, which sets
   forth information with respect to the Selling Holders (as defined in the
   Prospectus) and the respective amounts of Convertible Preferred
   Securities beneficially owned by each Selling Holder that may be offered
   pursuant to the Prospectus (as supplemented and amended), is hereby
   amended by the deletion of item 46 of that table and the substitution
   therefor of the following:

                         Convertible                         
                         Preferred                           
                         Securities           Number of      Convertible   
                         Owned                Convertible    Preferred    
                         Prior to             Preferred      Securities Owned
                         Offering             Securities     After Offering  
     "Selling Holder     Number   Perent      Offered        Number   Percent
                                                             

    46.  Morgan          402,900  10.07%      227,800        175,100   4.38%"
         Stanley & Co.,         
         Inc.

        Morgan Stanley & Co. Incorporated and its affiliates have performed
   various investment banking, commercial banking, fiduciary and other
   services for McKesson in the past, and may do so from time to time in
   the future.

        The Prospectus, together with this Prospectus Supplement,
   constitutes the prospectus required to be delivered by Section 5(b) of
   the Securities Act of 1933, as amended, with respect to offers and sales
   of the Convertible Preferred Securities and McKesson Common Stock
   issuable upon conversion of the Convertible Preferred Securities. All
   references in the Prospectus to "this Prospectus" are hereby amended to
   read "this Prospectus (as supplemented and amended)".

   PROSPECTIVE INVESTORS SHOULD CAREFULLY CONSIDER MATTERS DISCUSSED UNDER
   THE CAPTION "RISK FACTORS" BEGINNING ON PAGE 6 OF THE PROSPECTUS.

   THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES
   AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS THE
   SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION
   PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY
   REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

   The date of this Prospectus Supplement is September 25, 1997.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission